Literature DB >> 1484728

Lipid profiles in spinal cord injury.

D Cardús1, F Ribas-Cardús, W G McTaggart.   

Abstract

Measurement of blood levels of total cholesterol and lipoproteins (HDL and LDL) were conducted on 96 men with spinal cord injury, 46 paraplegics and 50 quadriplegics. All these patients were studied in the stabilized phase of the disease as a follow up to the rehabilitation process. The study was designed to compare results with a normal, able bodied population and to investigate if any abnormal finding could be related to the age at onset of the spinal cord injury, the duration of the disease or the level of the lesion. Compared to the normal, able bodied population, this study indicates that patients with a spinal cord injury do not have higher levels of cholesterol or LDL, nor lower levels of HDL. Levels of total cholesterol increase with aging, as in the normal population, but have no relation to the duration of the disease or the level of the lesion. Blood levels of HDL and LDL do not seem to be related either to the duration of the disease or to the level of the lesion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484728     DOI: 10.1038/sc.1992.149

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  4 in total

1.  Risk factors for atherogenesis in children with spina bifida.

Authors:  C Rendeli; M Castorina; E Ausili; E Girardi; C Fundarò; M Caldarelli; E Salvaggio
Journal:  Childs Nerv Syst       Date:  2004-04-07       Impact factor: 1.475

Review 2.  Spinal cord injury, exercise and quality of life.

Authors:  L Noreau; R J Shephard
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

3.  Fundamental hemodynamic mechanisms mediating the response to myocardial ischemia in conscious paraplegic mice: cardiac output versus peripheral resistance.

Authors:  Heidi L Lujan; Stephen E DiCarlo
Journal:  Physiol Rep       Date:  2017-03

Review 4.  Metabolic Dysfunction in Spinal Muscular Atrophy.

Authors:  Marc-Olivier Deguise; Lucia Chehade; Rashmi Kothary
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.